- $45.59m
- $71.25m
- $80.28m
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview
TELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants
TELA Bio Q3 revenue misses estimates
Brief: Tela Bio Appoints William Plovanic To Board Of Directors
Brief: Tela Bio Announces Addition Of Betty Jo Rocchio To Board Of Directors
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio misses Q2 revenue estimates
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Tela Bio Announces Inducement Grant Under Nasdaq Listing Rule
Tela Bio Inc Reports Results For The Quarter Ended March 31: Earnings Summary
Brief: TELA Bio Q1 Revenue USD 18.52 Million Vs. IBES Estimate USD 17.4 Million